Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CHOP Plus Rituximab (CHOP-R) in Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) or CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)

NCT00309881 is registered in ClinicalTrials.gov with German CLL Study Group as lead sponsor.

NCT NCT00309881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00309881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CHOP Plus Rituximab (CHOP-R) in Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL) or CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)
Lead sponsor
German CLL Study Group
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2003
Completion date
March 31, 2011
Enrollment
75 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia